CD8A and COVID-19: An analysis of 452 patients, 286 with severe COVID-19, exhibited a reduction of CD4+, CD8+ and regulatory T lymphocytes, a reduction of monocytes, eosinophils and basophils, and an increase in the neutrophil-to-lymphocyte ratio (NLR) (44).